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Interventional Neuroradiology: Henry Ford Hospital Experience 
with Nonembolization Procedures 
Clifford R. Jack, Jr, MD,* Bharat A. Mehta, MD,* Roushdy S. Boulos, MD, PhD,* 
Suresh C. Patel, MD,* James I. Ausman, MD, PhD,+ and Ghaus M. Malik, MD^  
Innovative technical developments over the past two decades have resulted in the development ofa 
variety of useful interventional procedures for minimally invasive treatment of a variety of head and 
neck lesions. We have had experience with four different types of nonembolization interventional 
neuroradiologic procedures at Henry Ford Hospital from 1981 through 1985. 
Percutaneous transluminal angioplasty of six external carotid artery stenoses has been performed 
in five patients. Five were successful, and the artery became occluded in one patient. Intracarotid 
BCNU infusion was performed successfully in five patients with recurrent astrocytoma. Intraarterial 
streptokinase infusion was performed in one patient with acute thrombosis of an ectatic basilar artery. 
A traumatic carotid cavernous fistula was successfully closed by detachable silicone balloon 
technique. (Henry FordHosp MedJ 1986,34:11-18) 
The search for less invasive ways to treat a variety of abnor-malities involving virtually every organ system has led to 
rapid growth in the field of interventional radiology. In recent 
years, interventional radiologic techniques have played an in-
creasingly important role in the treatment of a variety of lesions 
of the head, neck, and spine, giving rise to the high sub-
specialized field of interventional neuroradiology. 
A number of technical innovations within the past two de-
cades have stimulated the development of a variety of useful and 
increasingly successful interventional neuroradiologic pro-
cedures. The list of therapeutic procedures that have been ap-
plied to the treatment of head and neck abnormalities include: 
percutaneous transcatheter embolization of vascular tumors and 
vascular malformation (1,2); percutaneous transluminal an-
gioplasty (PTA) (3-9); ti-ansluminal detachable, occlusive, and 
leak-calibrated balloons (10-15); and intracranial drag infusion 
made possible by better catheter delivery systems (16-20). 
In fliis paper we discuss only the nonembolization interven-
tional neuroradiologic procedures performed at Henry Ford 
Hospital. Indications, benefits, risks, and technical guidelines 
are discussed for each procedure. 
Patients, Methods, and Results 
Twelve patients have undergone nonembolization interven-
tional neuroradiologic procedures at Henry Ford Hospital from 
1981 through 1985. All procedures were performed by one of the 
authors (Mehta) in the Department of Radiology, Division of 
Neuroradiology. To date, we have experience with four different 
types of nonembolization procedures. 
Percutaneous transluminal angioplasty (PTA) of the exter-
nal carotid artery (ECA) 
Patients—Six such procedures have been performed in five 
patients. Bilateral ECA-PTA was performed in the same sitting 
in one patient. All patients were elderly, with atherosclerotic oc-
clusion of the ipsilateral intemal carotid artery (ICA) and ath-
erosclerotic stenosis at the origin of the ipsilateral ECA. These 
patients were to undergo superficial temporal artery to middle 
cerebral artery bypass procedures but had ipsilateral external 
carotid stenoses. The PTA was performed to eliminate the need 
for extemal carotid endarterectomy before the bypass operation. 
Technique—The procedure was performed via the femoral 
approach in all but one patient, in whom a direct common ca-
rotid artery puncture was performed. A constant intravenous 
heparin infusion was maintained throughout each procedure. A 
5 French polyethylene Dotter Balloon Dilatarion Catheter 
(Cook, Bloomington, IN) with a 4 mm (inflated diameter) bal-
loon was positioned across the stenotic ECA lesion under fluo-
roscopic guidance. The balloon was inflated three times for 30 
seconds each. The balloon catheter was then withdrawn into the 
common carotid artery, and a postdilatation angiogram was 
performed. 
Results—Increase in lumen size of the affected segment of 
50% to 70% was achieved in five arteries (Fig 1). No neurologic 
complications were encountered in any of these patients. 
The ECA became occluded in the patient who underwent di-
rect carotid artery puncture. She developed a mild contralateral 
hemiparesis following the procedure, which resolved in two 
months. This patient was shown at subsequent endarterectomy 
to have had a large, heavily calcified atherosclerotic plaque pro-
ducing the stenosis. 
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Fig I—External carotid PTA in patients with occluded ipsilateral ICA .(A) Predilatation and (B) postdilatation AP view right carotid 
injection showing 50% increase in size of stenotic ECA segment (arrow). 
Intracarotid L3-Bis(2-chloroethyl)-l-nitrosourea (BCNU) 
infusion 
Patients—Six such procedures have been perfonned in five 
patients. These patients ranged in age from 27 to 60. All patients 
had end stage, grade 3 to 4, unilateral supratentorial astro-
cytomas. All tumors were recurrent (postsurgical resection), 
and all were then treated with a combined radiation therapy-
intracarotid chemotherapy approach. 
Technique—Via transfemoral approach, a 5 French catheter 
was placed in the petrosal segment of the ICA ipsilateral to the 
tumor. Twenty-five grams of mannitol in saline were infused 
through the catheter rapidly. A solution of 100 mg/m^ BCNU in 
49 mL of normal saline and 1 mL absolute ethanol (solvent for 
BCNU) was then infused through the catheter via a micropump 
(Sigma Motor, Inc, Middleport, NY) over 15 minutes. The pa-
tients were carefully monitored for signs of neurologic and 
ocular toxicity during infusion. 
Results—No neurologic deficit, seizure activity, vision loss, 
myelosuppression, or GI toxicity was produced. One patient did 
experience retro-orbital pain during infusion with no permanent 
sequelae. 
Results conceming survivorship or improved neurologic sta-
tus are inconclusive in comparison to other chemotherapeutic 
regimes due to the small number of patients included. All 
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Fig2(A)—Intraarterial streptokinase infusion for basilar artery 
thrombosis. AP view of left vertebral artery injection showing 
massive ectasia of basilar artery. A 3 cm thrombus partially 
occludes rostral basilar artery (arrow). 
patients did eventually die. Well-controlled data with documen-
tation of the effect of intraarterial BCNU on tumor size by 
computed tomography (CT) are not available. 
Intraarterial streptokinase infusion for basilar artery 
thrombosis 
Patients—This procedure was performed on an emergency 
basis in one patient. This 66-year-old man presented with 
rapidly progressing multiple cranial nerve deficits and de-
creased level of consciousness over the course of several hours. 
Emergency cerebral angiography demonstrated marked diffuse 
ectasia ofthe basilar and the intracranial left vertebral artery 
with nearly complete occlusion of the rostral basilar artery by a 
3 cm intraluminal thrombus. 
Technique—Twelve to 14 hours after onset of symptoms, the 
interventional procedure was begun. A Berenstein catheter 
(USCI, Bellerica, MA) was placed transfemorally into the cer-
vical left vertebral artery at the C2 level. Through this, a 0.038 
removable core hollow wire (USCI) was coaxially placed into 
the basilar artery, just proximal to the thrombus. Through the 
hoUow wire 350,000 units of streptokinase (Streptase, Hoechst-
Roussel, NS) was infused over three hours using a microdrip 
pump (Sigma Motor, Inc). This was accompanied by low-dose 
systemic heparinization. The entire procedure was performed 
on the angiography table, with constant monitoring of the pa-
tient's clinical status. Three angiographic studies were per-
formed to assess morphologic change in the thrombus. 
Fig 2(B)—Intraarterial streptokinase infusion for basilar artery 
thrombosis. AP scout radiograph showing position of hollow 
wire tip in midbasilar artery (arrows). 
Results—Slow but progressive improvement in the patient's 
level of sensorium was noted over the first three hours of infu-
sion. At three hours, however, a sudden decreased level of con-
sciousness was noted, and the infusion was tenninated. Diag-
nostic angiographic studies performed over the course of the 
streptokinase infusion demonstrated no change in thrombus 
size. 
The patient unfortunately died two days later. Autopsy re-
vealed extensive brain stem and cerebellar infarction, producing 
marked posterior fossa mass effect and tonsillar hemiation, with 
no evidence of intracranial hemonhage (Fig 2). A recent embo-
lus was also present in the left posterior cerebral artery, produc-
ing infarction of the left occipital lobe. The basilar artery was 
markedly ectatic with little evidence of atherosclerosis and uni-
formly absent intemal elastic lamina. The thrombus appeared to 
have formed without an atherosclerotic substrate, due to stasis 
within the basilar artery. 
Detachable balloon occlusion of carotid-cavernous fistula 
Patient—This procedure has been performed in one patient to 
date, a 64-year-old man who presented with a posttraumatic 
high-flow carotid-cavemous fistula on the right. He was symp-
tomatic from a constant loud brait that interfered with sleep and 
a cavernous sinus syndrome consisting of ipsilateral cranial 
nerve 3,4, and 6 palsy. 
Technique—The procedure was performed using a Becton-
Dickinson (Rutherford, NJ) detachable silicone balloon system 
that comes premade from the manufacturer (12). The cylindric 
silicone rabber balloon (2x7 mm uninflated) is attached to a 150 
cm 3 French polyurethane catheter via a stainless steel pressure-
activated valve pin. This balloon-tipped catheter was introduced 
coaxially through a 9 French straight catheter that had been 
placed transfemorally into the proximal right ICA. The balloon 
was flushed with normal saline into the fismla via flow direction 
technique (12). The balloon was inflated wifli 0.6 mL of 210% 
Amipaque (Winthrope-Breon Lab, New York, NY). A DSA ran 
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Fig 2f C)—Intraarterial streptokinase infusion for basilar 
artery thrombosis. AP left vertebral injection ctfter two and one 
half hours of streptokinase infusion shows no change in size of 
basilar thrombus (arrow), although the patient was improved 
clinically at this point. 
was taken to document satisfactory balloon position, effect on 
fistula flow, and morphology of the adjacent carotid siphon. 
When the aforementioned criteria had been met, the balloon was 
detached. Two detachable silicone balloons were placed by this 
technique. 
Results—The first balloon was successfully placed into the 
fistulous opening, resulting in immediate subjective cessation of 
the brait. After one hour, the brait retumed suddenly. A DSA 
study was performed that revealed migration of the baUoon from 
the fistulous opening into the cavernous sinus with reopening of 
flow through the fistula. A second balloon was then successfully 
placed into the fismlous opening, again with subjective relief of 
the brait. At one month follow-up, neither baUoon had changed 
position, and the patient remained asymptomatic (Fig 3). No 
complications were encountered during placement of either bal-
loon. Marked clinical improvement in the right cavemous sinus 
syndrome was noted within 24 hours. 
Discussion 
In recent years, interventional neuroradiologic procedures 
have increasingly been employed with much success in the man-
agement of a variety of head and neck conditions. This paper is 
limited to a discussion of the four types of nonembolization in-
terventional neuroradiologic procedures to date at this 
institution. 
Percutaneous transluminal angioplasty of the external 
carotid artery 
The technique of PTA was pioneered by Grantzig in the 1970s 
and has since been applied extensively in treatment of local areas 
Fig 2(D)—Intraarterial streptokinase infusion for basilar 
artery thrombosis. Gross specimen of ectatic basilar circulation 
at autopsy. 
of arterial stenosis involving many organ systems (6,7). This 
technique has proved to be especially useful in the treatment of 
coronary artery disease, peripheral vascular disease, and reno-
vascular hypertension (6,7). 
Several authors have reported the application of PTA in the 
treatment of stenotic arterial lesions of the extracranial carotid 
and vertebral circulation. Successful dilatation of cervical ICA 
stenoses due to fibromuscular dysplasia (8) and of carotid and 
vertebral artery atherosclerotic stenoses (3,4) has been reported. 
Atherosclerotic stenosis of the cavemous-carotid artery has also 
been dilated successfully (9). Due to the risk of distal emboliza-
tion and possible stroke, PTA for atherosclerotic ICA lesions is 
recommended only for patients who are not surgical candidates 
(3,4). 
The risk of stroke is minimized in dUatation of ECA stenoses 
in patients with ipsilateral ICA occlusion. Successful dilatation 
of ECA stenosis in nine patients before superficial temporal to 
middle cerebral artery bypass for ICA stenosis without neu-
rologic complication has been reported by Vitek (5). 
This procedure is not without risk. An intimal tear or intra-
mural hematoma may be produced that could lead to ECA occlu-
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Fig 2 (E)—/ntraart erial streptokinase infusion for basilar artery 
thrombosis. Cross section of basilar artery showing intra-
luminal thrombus. 
sion, as happened in one of our cases. Wide fluctuations in blood 
pressure are also possible due to pressure on chemoreceptor 
cells in the adjacent carotid bulb (3). Emboli may reach the intra-
cranial circulation even with cervical ICA occlusion in patients 
with reti-ograde ophthalmic collateral flow. 
Poor results have been reported in attempting to dilate heavUy 
calcified stenotic plaques (4). Both the poor results reported in 
the literature as well as our experience with one patient in whom 
PTA faUed leads us to concur that patients with calcified plaques 
are not candidates for this procedure. 
Intracarotid BCNU infusion in recurrent astrocytoma 
Anaplastic glioma accounts for approximately one fourth of 
all adult cerebral neoplasms and includes glioblastoma multi-
form, anaplastic astrocytoma, and malignant astrocytomas. 
These tumors have a uniformly fatal course with less than 10% 
survivorship at two years (21). A mean survival of 17 weeks is 
reported with surgical resection alone (22). With the addition of 
radiation therapy, mean survival is extended to 37.5 weeks (22). 
The best result reported in patients treated with resection, radia-
tion therapy, plus systemic BCNU is a survival of 51 weeks (22). 
Although this combined approach has resulted in prolonged sur-
vival and improved neurologic function, the long-term prog-
nosis remains poor (23-28). 
BCNU does cross the blood-brain barrier and has been shown 
to be the most effective single chemotherapeutic agent against 
glioma (17,21). A response rate of 50% with a mean duration of 
Fig 3(A)—Detachable balloon occlusion of carotid cavernous 
fistula. CT scan showing enlargement of right cavernous sinus 
(arrow) due to high-flow CCflstula. 
Fig 3(B)—Detachable balloon occlusion of carotid cavernous 
fistula. Lateral view of right ICA injection showing opacifi-
cation of right cavernous sinus (hollow arrow) by flow through 
fistula. Venous drainage is via inferior petrosal sinuses 
bilaterally (solid arrows). 
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Fig 3(C)—Detachable balloon occlusion of carotid cavernous 
flstula. Lateral view of right ICA injection after flstula closure. 
No opacification of cavernous sinus is present (compare with 
Fig 3B). Two balloons are identifiable as subtracted images 
(arrows). 
nine months' response has been reported for recunent astro-
cytoma with systemic BCNU therapy alone (23). Unfortunately, 
side effects of systemic treatment can be severe. Delayed my-
elosuppression (particularly thrombocytopenia) is the chief side 
effect, with gastrointestinal toxicity also reported (18,23,24). 
There is evidence indicating cumulative myelotoxicity for 
BCNU, a problem limiting the total amount that may be given 
(23,24). 
The goal of intracarotid BCNU infusion is to achieve high in-
tratumoral drag levels with low systemic levels, thereby max-
imizing antitumoral drag activity and minimizing systemic side 
effects. Work with monkeys has shown that intraarterial BCNU 
administration results in 190% to 280% higher brain, nucleic 
acid-bound drag levels than systemic administration (17). Intra-
carotid BCNU has been shown to shrink astrocytomas by CT 
criteria, though no remission has been documented with this 
technique (20). Improved survivorship with this technique in 
comparison to systemic BCNU administration has been re-
ported in a series of 30 patients by Greenberg (22). However, no 
randomized studies with this technique have been reported. 
The major risk reported for intracarotid BCNU infusion is ip-
silateral retinal toxicity, including retro-orbital pain during infu-
sion, retinal vasculitis, and even blindness (20,27). This is be-
cause the ophthalmic artery receives high drag concentration 
with high cervical ICA catheter tip placement. Decreasing the 
ethanol concentration of the mixmre seems to decrease the se-
verity of retinal toxicity; however, it is not yet clear whether the 
offending agent is ethanol alone, or BCNU as well (21,27). Ip-
silateral cerebral infarction is a less widely reported complica-
tion (16,18). 
Supraophthalmic BCNU infusion through a microballoon or 
hollow wire threaded coaxially through a polyurethane catheter 
with its tip in the cervical ICA is possible (14,15). Successful 
supraophthalmic BCNU infusion has been reported using cali-
brated leak microballoons with no retinal toxicity (28). Super-
selective catheterization of the specific intracranial vessels sup-
plying the tumor may also be possible, in which case much of 
the normal brain parenchyma ipsilateral to the tumor may be 
spared exposure to high concentrations of BCNU. However, the 
safety and efficacy of superselective intraarterial BCNU infu-
sion directly into tumor vessels have not been definitively estab-
lished, and this approach must, at this point, be regarded as 
experimental. 
Intracarotid mannitol was given in our series of patients to 
temporarily modify the blood-brain barrier and to increase de-
livery of BCNU to tumor tissue in our protocol (29). However, 
the efflcacy of this step in achieving greater delivery of BCNU to 
tumor tissue has recently been questioned (27). 
Intraarterial streptokinase infusion for basilar artery 
thrombosis 
Basilar artery thrombosis has been a very poor prognosis. In a 
series of 22 cases of angiographically proven basilar artery oc-
clusion by Thompson et al, 44% of these patients died within 
three months (30). Archer and Homstein published 20 cases of 
angiographically proven basilar artery occlusion; 70% of these 
patients died within three and a half months (31). Those patients 
with rostral basilar artery thrombosis had an even poorer prog-
nosis than those with more proximal occlusion (31). To date, 
no effective surgical therapy is available for basilar artery 
thrombosis. 
Successful intraarterial clot lysis has been achieved using 
both intravenous (IV) and intraarterial (IA) streptokinase 
(19,32-35). IV streptokinase in doses of 100,000 units/hr results 
in successful intravascular clot lysis (34). However, mainte-
nance of systemic streptokinase levels in this therapeutic range 
regularly results in unwanted bleeding at distal sites, particu-
larly recent surgical incisions and needle puncture sites (34). 
The purpose of IA administration is to maximize drag levels 
at the target site, while minimizing systemic levels. IA strep-
tokinase in doses of 10,000 units/hr results in the same degree of 
intravascular clot lysis as 100,000 units/hr administered sys-
temically, without the unwanted systemic side effects (34). IA 
streptokinase infusion has been proven effective in clot lysis 
(without distal hemonhagic complications) at a number of dif-
ferent locations, including peripheral and pulmonary arterial 
circulation (32), peripheral arterial grafts, renal dialysis ac-
cesses (33), and coronary circulation (35). 
The catheter used for streptokinase infusion may lie for a 
fairly long period within the relatively stagnant column of blood 
proximal to an obstracting thrombus. Simultaneous systemic 
heparinization is therefore recommended to prevent new throm-
bus formation on the catheter (33). 
Zeumer et al have reported five cases of IA streptokinase infu-
sion for angiographically proven basilar artery thrombosis (19). 
Three of these five patients demonstrated dramatic functional 
16 Henry Ford Hosp Med J—Vol 34, No 1, 1986 Nonembolization Procedures—Jack et al 
improvement and prevention of further ischemic necrosis. One 
patient died, and one remained "locked in," unchanged from 
the preinfusion state. A dose of 100,000 units/hr for two hours 
was used in all patients with no CT evidence of intracranial hem-
onhage (19). 
In the case we report, autopsy revealed no evidence of signifi-
cant atherosclerotic plaque formation in the intracranial ver-
tebrobasilar system. Therefore, we postulate that the most likely 
cause of thrombus formation is stasis due to massive basilar ec-
tasia (33). Because of tiie grave namre of this patient's problem 
and the rapid rate of clinical deterioration, we felt that anything 
less than a maximally aggressive therapeutic approach would 
produce a certaiifly fatal outcome. At autopsy, embolic occlu-
sion ofthe left posterior cerebral artery and extensive brain stem 
infarction were found. We postulate that die large basilar throm-
bus was "broken up" by streptokinase infusion into multiple 
smaller clots which embolized distally. 
Because ofthe small number of cases reported, risks have not 
been established for this procedure, but certainly embolization 
of basilar branches due to clot "break up" would be a major the-
oretical risk. Intracranial hemonhage would be a second major 
theoretical risk; however, this was not seen in our case, nor in the 
cases reported by Zeumer (19). 
The goal in intracranial arterial clot lysis must be dissolution 
of the clot exterior, layer by layer, peeling it like an "onion 
skin." Formation of smaller clot fragments, which migrate dis-
tally, producing embolic tissue infarction may be tolerated in the 
peripheral vasculature but not in the central nervous system. Fur-
ther experimental work must be done to suitably modify this 
technique for widespread use in central nervous system intraar-
terial thrombolysis. 
IVansluminal detachable balloon occlusion of carotid-
cavernous fistula 
The term carotid-cavemous (CC) fistula is used to describe 
two anatomically distinct vascular abnormalities. In both cases, 
an abnormal fistulous connection exists between arteries adja-
cent to the cavemous sinus and the sinus itself. This fistulous 
channel produces abnormal shunting of arterial blood directly 
into the cavemous sinus (10). 
When the arterial supply to the fistula is from small dural 
branches of the ICA or the ECA, the rate and volume of flow is 
often minimal. This type of carotid-cavernous fistula usually 
does not pose a serious clinical problem, and often is merely an 
incidental finding at cerebral angiography. Spontaneous closure 
ofthis type of fistula is the rale and, flierefore, no form of fi-eat-
ment is recommended (10). 
IL however, the arterial supply to the fistula is through a tear 
in the cavemous ICA itselL then flow through the fistula is often 
of high rate and volume. This type of CC fistula may produce 
severe clinical symptoms. The rapid arterial to venous shunting 
elevates the pressure within the cavemous sinus and the venous 
channels which normally drain into or out of the sinus (10). Ele-
vation of pressure within the cavemous sinus may result in dys-
function of cranial nerves 3, 4, 6, and 5 (particularly the first 
division). Elevation of venous pressure within the orbit may pro-
duce exophthalmus and, more importantly, vision loss. These 
symptoms are most commonly seen ipsilateral to the fistula but 
due to normally present transcavemous venous channels may be 
bilateral or rarely contralateral to the fistula. This high-flow type 
of CC fistula most commonly results from trauma or from spon-
taneous rapture of a cavemous ICA aneurysm. These, in gen-
eral, do not close spontaneously, and ti-eatment is recommended 
because of the danger of permanent blindness and/or ocular 
palsy (10). Carotid-cavemous fistulas that drain predominantly 
posteriorly may produce a cavemous sinus syndrome and a loud 
brait, without significant orbital symptoms. 
A variety of approaches have been used to treat high-flow CC 
fistulae. The list includes simple ligation of the ipsilateral ICA 
or common carotid artery in the neck, trapping of the ICA with 
or without fistula embolization, or intraluminal balloon occlu-
sion of the cavernous ICA (11,36). Copper wires have been 
placed into the cavemous sinus with or without electric cunent 
to induce thrombosis (36). A procedure recentiy described by 
Diaz et al involves ICA ti-apping combined with an ipsilateral 
bypass of the superficial temporal to the middle cerebral artery 
in the sylvian fissure (11,36). 
Detachable baUoon occlusion of the fistula itself is theo-
retically the best procedure for treatment of this condition 
because the fistula is closed without occluding the ipsilateral 
ICA (11). 
Two different types of detachable balloons have been devel-
oped. Latex balloons were developed first but have been sup-
planted in many centers by the silicone balloon we have de-
scribed (11,12). 
The latex balloon must be hand-tied (often difficult and time 
consuming) with a ligature at the end of a single lumen catheter 
This balloon must be maneuvered into the fistula and detached 
with a coaxially placed 8 French outer single lumen catheter It 
is often difficult to maneuver an 8 French catheter into the caver-
nous carotid artery, and the risk of damage to the vessel wall 
from a catheter this large is significant. A second catheter must 
be placed in the opposite groin and placed in the ipsilateral 
carotid artery to perform diagnostic angiographic runs. The 
balloon ligature is inherently weak, and partial or complete 
balloon deflation is a problem. Latex balloons also incite tissue 
reaction (12). 
We prefer the silicone detachable balloons because they are 
more maneuverable, have less premature deflation, come ready 
to use from the manufacturer, do not require placement of a sec-
ond catheter in the opposite groin, and incite little if any tissue 
reaction (12). The one advantage latex balloons have is greater 
distensibility. Because they can be inflated to larger diameter, 
one latex balloon is usually sufficient to achieve fismla closure. 
Conversely, up to six silicone balloons may be required to close 
or sufficiently reduce fistula flow. 
Use of either silicone or latex balloons is not without risk. The 
most serious potential complication is distal embolization of the 
intracranial carotid circulation by a prematurely detached or de-
flated balloon, which may produce stroke. Palsy of cranial 
nerves 3, 4, 6, 5 (first division), and 7 have been reported 
(11-13). These are nearly always temporary when they do occur 
If a balloon is overinflated in the cavemous sinus and later de-
flates, a false aneurysm may be produced. Trauma to the low 
cervical ICA by the outer 9 French coaxial cadieter may rarely 
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cause perforation, false aneurysm, dissection, or occlusion 
(1L12). 
Angiographically complete fistula closure is not commonly 
achieved. Silicone balloons are individually placed until 
the fistula flow is slowed significantly, and the subjective brait 
experienced by the patient disappears. When this end point 
is achieved, the cavernous sinus will usually thrombos spon-
taneously within weeks. The fistula will then not recur, even 
with balloon deflation. This instant and dramatic resolution in 
symptoms can be one of the most elegant and gratifying pro-
cedures in medicine. 
Summary 
We have had experience with four different types of nonem-
bolization interventional neuroradiologic procedures at Henry 
Ford Hospital. Detachable balloon occlusion of CC fistula is an 
elegant procedure with well-documented clinical efficacy. PTA 
of the ECA, intracarotid BCNU infusion for glioblastoma, and 
intraarterial streptokinase for basilar thrombosis are relatively 
new or experimental procedures and, therefore, not widely re-
ported in the literature. The full range of clinical applicability of 
the latter three procedures has yet to be realized. 
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